DZIF

Contact
dzif.de
+49 5316181 1152

Deutsches Zentrum für Infektionsforschung e.V.

Inhoffenstraße 7
38124 Braunschweig
Germany
+49 5316181 1152
dzif.de
Contact
Profile News
Contact

About DZIF

Read more about DZIF
Facts about DZIF
  • Industry : Healthcare

News about DZIF

DZIF

01-Apr-2026 | science

Development of a rapid test for diagnosing hard-to-treat VRE Bacteria

Vancomycin-resistant Enterococcus faecium (VRE) is among the most concerning antibiotic-resistant pathogens, as treatment options are severely limited. The ...

Read news
DZIF

17-Sep-2025 | science

How HIV enters the genome – Researchers identify previously unknown mechanism

The results provide new therapeutic approaches for specifically controlling HIV reservoirs in the body

Read news
DZIF

23-Jul-2025 | science

Data-driven detection of concerning SARS-CoV-2 variants months in Advance

Online tool can detect and characterize SARS-CoV-2 Variants of Concern up to three months before their formal designation of the WHO

Read news
DZIF

05-Jun-2025 | science

Broad-spectrum antiviral compounds discovered

Computer-identified drug candidates successfully confirmed by laboratory experiments

Read news
DZIF

15-Apr-2025 | science

Gut microbiome as a predictive factor for kidney rejection?

Study establishes a link between microbial changes in the gut microbiome and transplant rejection and graft dysfunction

Read news
DZIF

18-Dec-2024 | business & finance

Start-up EBViously founded

Innovative vaccine based on virus-like particles

Read news
DZIF

26-Nov-2024 | science

An innovative antibiotic class for drug-resistant bacteria

New active compounds inspired by a bacterium

Read news
DZIF

23-Oct-2024 | science

Chemical trick activates antibiotic directly at the pathogen

Click-to-release technique avoids the severely nephrotoxic effect of colistin

Read news
DZIF

22-Aug-2024 | science

New vector vaccine against COVID-19 provides long-term protection

Established vaccines against COVID-19 are known to have the disadvantage that the initially good protective effect wears off relatively quickly. This makes ...

Read news
DZIF

02-May-2024 | science

New mode of action in the "bacterial war" decoded: Possible alternative to antibiotics produced by bacteria

Antibacterial substance from staphylococci discovered with new mechanism of action against natural competitors

Read news
DZIF

24-Aug-2023 | science

Researchers decode new antibiotic

Combined attack minimizes resistance development

Read news
DZIF

08-Aug-2023 | science

A promising investigational therapeutic monoclonal antibody to treat chronic hepatitis B and D infections

Affecting hundreds of millions of people, chronic hepatitis B is a widespread global health problem for which there is as yet no cure. In a preclinical ...

Read news
DZIF

13-Jun-2023 | science

How the gut microbiome responds to antibiotics

Antibiotics affect the composition and dynamics of the gut microbiome. Treatment with antibiotics not only leads to a loss of biodiversity of microorganisms ...

Read news
DZIF

17-May-2023 | science

Infection with common cold coronaviruses can trigger broad cross-immunity against SARS-CoV-2 proteins

Researchers at the University Medical Center Hamburg-Eppendorf have demonstrated cross-reactive immune responses to another SARS-CoV-2 protein besides the ...

Read news
DZIF

12-Apr-2023 | research and development

Novel vaccine against a range of diseases caused by the Epstein-Barr virus

Start-up “EBViously“ announces first details of its EBV vaccine candidate

Read news
Show more news about DZIF

Here you will find Deutsches Zentrum für Infektionsforschung e.V.

Last viewed contents

Highly efficient production of advanced biofuel by metabolically engineered microorganism - Combining systems metabolic engineering and downstream process, production of butanol could be dramatically increased

Go to page

Cyclin D1 governs microRNA processing in breast cancer - Cyclin D1 controls cell cycle progression and microRNA biogenesis through Dicer -- a new mechanism promoting breast cancer

Go to page

Keith Powell hands over to John Burt to lead PolyTherics

Go to page
Breast milk as a weapon against cancer

Breast milk as a weapon against cancer

Go to page

Dyax Corp. Recognized as a "Top Place to Work" by The Boston Globe

Go to page

Using microbes for the quick clean up of dirty oil

Go to page

Cenix BioScience and Schering AG Sign Research Agreements to Advance Several Disease Programs

Go to page

OctoPlus signs service contract with Axentis Pharma

Go to page